In this Issue
TNM Classification and Clinicopathological Factors
The Challenge of Malignant Pleural Mesothelioma
Ki-67 Antigen in Lung Neuroendocrine Tumors
HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib
Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances
Detection of Rearrangements and Transcriptional Up-Regulation of ALK in FFPE Lung Cancer Specimens Using a Novel, Sensitive, Quantitative Reverse Transcription Polymerase Chain Reaction Assay
Phase I Safety and Pharmacokinetic Study of the PI3K/mTOR Inhibitor SAR245409 (XL765) in Combination with Erlotinib in Patients with Advanced Solid Tumors
Discovery of New Membrane-Associated Proteins Overexpressed in Small-Cell Lung Cancer
Impact of Extratumoral Lymphatic Permeation on Postoperative Survival of Non–Small-Cell Lung Cancer Patients
RANKL Inhibition Blocks Osteolytic Lesions and Reduces Skeletal Tumor Burden in Models of Non–Small-Cell Lung Cancer Bone Metastases
Survival in Women with NSCLC
Postoperative Pain and Subsequent Ptsd-Related Symptoms in Patients Undergoing Lung Resection for Suspected Cancer
EBUS-TBNA in Elderly Patients with Lung Cancer
Absence of a Relationship between Tumor 18F-fluorodeoxyglucose Standardized Uptake Value and Survival in Patients Treated with Definitive Radiotherapy for Non–Small-Cell Lung Cancer
Comparative Outcomes of Elderly Stage I Lung Cancer Patients Treated with Segmentectomy via Video-Assisted Thoracoscopic Surgery versus Open Resection
Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?
A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy
Failure Patterns Relative to Radiation Treatment Fields for Stage II–IV Thymoma
NCIC CTG IND.190 Phase I Trial of Dalotuzumab (MK-0646) in Combination with Cisplatin and Etoposide in Extensive-Stage Small-Cell Lung Cancer
Systemic Therapy, Clinical Outcomes, and Overall Survival in Locally Advanced or Metastatic Pulmonary Carcinoid
HIP1–ALK, a Novel Fusion Protein Identified in Lung Adenocarcinoma
Atypical Negative ALK Break-Apart FISH Harboring a Crizotinib-Responsive ALK Rearrangement in Non–Small-Cell Lung Cancer
Cerebral Nocardiosis Mimicking Multiple Brain Metastases in a Patient with Locally Advanced Non–Small-Cell Lung Cancer
Crizotinib Can Overcome Acquired Resistance to CH5424802
Emerging Evidence of a Clinical Quality Registry as a Driver of Improvement in Lung Cancer Outcomes